| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB6D RAD51B ATP5PB CHD9 RGS11 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 DNAH12 ARL8B DNM3 SMARCA4 ATP11A RAB37 HSPA1A HSPA1B TAP2 | 2.25e-06 | 775 | 154 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB6D RAD51B ATP5PB CHD9 RGS11 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 DNAH12 ARL8B DNM3 SMARCA4 ATP11A RAB37 HSPA1A HSPA1B TAP2 | 7.35e-06 | 839 | 154 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB6D RAD51B ATP5PB CHD9 RGS11 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 DNAH12 ARL8B DNM3 SMARCA4 ATP11A RAB37 HSPA1A HSPA1B TAP2 | 7.48e-06 | 840 | 154 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB6D RAD51B ATP5PB CHD9 RGS11 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 DNAH12 ARL8B DNM3 SMARCA4 ATP11A RAB37 HSPA1A HSPA1B TAP2 | 7.48e-06 | 840 | 154 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51B ATP5PB MYH6 MYH7B CHD9 MSH4 MSH5 ZRANB3 DNAH12 NAE1 SMARCA2 SMARCA4 ATP11A HSPA1A HSPA1B TAP2 | 2.21e-05 | 614 | 154 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | transporter activity | RHCG ATP5PB CACNA1S PLSCR5 ANXA6 PRELID3B GJC1 SLCO1B3 SLC1A1 SLC66A1 CLDN2 RHAG SLC7A9 SLC9C1 PRELID3A CLCN1 CLCA2 SLC25A2 SLC6A5 CACNA1I CACNA1G ATP11A SLC2A13 TAP2 | 5.12e-05 | 1289 | 154 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.84e-05 | 127 | 154 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | GTPase activity | RAB6D RGS11 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 ARL8B DNM3 RAB37 | 7.02e-05 | 341 | 154 | 11 | GO:0003924 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.54e-04 | 14 | 154 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | adiponectin binding | 1.76e-04 | 3 | 154 | 2 | GO:0055100 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.76e-04 | 3 | 154 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | phospholipase D activator activity | 1.76e-04 | 3 | 154 | 2 | GO:1990583 | |
| GeneOntologyMolecularFunction | denatured protein binding | 1.76e-04 | 3 | 154 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.84e-04 | 37 | 154 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.21e-04 | 71 | 154 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | channel activity | RHCG ATP5PB CACNA1S ANXA6 GJC1 SLC1A1 CLDN2 RHAG SLC9C1 CLCN1 CLCA2 CACNA1I CACNA1G | 2.22e-04 | 525 | 154 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | RHCG ATP5PB CACNA1S ANXA6 GJC1 SLC1A1 CLDN2 RHAG SLC9C1 CLCN1 CLCA2 CACNA1I CACNA1G | 2.26e-04 | 526 | 154 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | GTP binding | RAB6D ANXA6 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 ARL8B DNM3 RAB37 | 2.65e-04 | 397 | 154 | 11 | GO:0005525 |
| GeneOntologyMolecularFunction | carbon dioxide transmembrane transporter activity | 3.51e-04 | 4 | 154 | 2 | GO:0035379 | |
| GeneOntologyMolecularFunction | adipokinetic hormone receptor activity | 3.51e-04 | 4 | 154 | 2 | GO:0097003 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 4.58e-04 | 83 | 154 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 4.66e-04 | 20 | 154 | 3 | GO:0015174 | |
| GeneOntologyMolecularFunction | ATP-dependent DNA damage sensor activity | 4.66e-04 | 20 | 154 | 3 | GO:0140664 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RAD51B POLH POLR2B CHD9 MSH4 MSH5 ZRANB3 POLR3A AGO4 SMARCA2 PTRH2 SMARCA4 CNOT1 CPSF3 | 4.82e-04 | 645 | 154 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 5.82e-04 | 5 | 154 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 5.82e-04 | 5 | 154 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | RAB6D ANXA6 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 ARL8B DNM3 RAB37 | 6.16e-04 | 439 | 154 | 11 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | RAB6D ANXA6 ARL8A RAB6C ARF1 ARF3 ARF4 ARF5 ARL8B DNM3 RAB37 | 6.16e-04 | 439 | 154 | 11 | GO:0019001 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | RHCG ATP5PB CACNA1S ANXA6 GJC1 SLCO1B3 SLC1A1 SLC66A1 CLDN2 RHAG SLC7A9 SLC9C1 CLCN1 CLCA2 SLC25A2 SLC6A5 CACNA1I CACNA1G SLC2A13 TAP2 | 7.61e-04 | 1180 | 154 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | DNA damage sensor activity | 8.08e-04 | 24 | 154 | 3 | GO:0140612 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 8.69e-04 | 6 | 154 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 8.69e-04 | 6 | 154 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 9.92e-04 | 262 | 154 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | phosphatidic acid transfer activity | 1.21e-03 | 7 | 154 | 2 | GO:1990050 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.33e-03 | 105 | 154 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 2.05e-03 | 9 | 154 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.58e-03 | 74 | 154 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ATP5PB CACNA1S ANXA6 GJC1 SLC1A1 SLC9C1 CLCN1 CLCA2 CACNA1I CACNA1G | 3.03e-03 | 459 | 154 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 3.11e-03 | 11 | 154 | 2 | GO:0000099 | |
| GeneOntologyBiologicalProcess | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 2.70e-06 | 53 | 154 | 6 | GO:0006890 | |
| Domain | ARF | 1.07e-07 | 29 | 152 | 6 | PS51417 | |
| Domain | Small_GTPase_ARF | 1.07e-07 | 29 | 152 | 6 | IPR024156 | |
| Domain | Arf | 1.64e-07 | 31 | 152 | 6 | PF00025 | |
| Domain | Small_GTPase_ARF/SAR | 2.43e-07 | 33 | 152 | 6 | IPR006689 | |
| Domain | P-loop_NTPase | RAD51B MYH6 MYH7B CHD9 ARL8A MSH4 MSH5 ZRANB3 RAB6C ARF1 ARF3 ARF4 ARF5 DNAH12 ARL8B SMARCA2 DNM3 SMARCA4 RAB37 TAP2 HYDIN | 5.33e-06 | 848 | 152 | 21 | IPR027417 |
| Domain | BRK | 1.04e-05 | 6 | 152 | 3 | SM00592 | |
| Domain | BRK_domain | 1.04e-05 | 6 | 152 | 3 | IPR006576 | |
| Domain | BRK | 1.04e-05 | 6 | 152 | 3 | PF07533 | |
| Domain | - | RAD51B CHD9 ARL8A MSH4 MSH5 ZRANB3 RAB6C ARF1 ARF3 ARF4 ARF5 DNAH12 ARL8B SMARCA2 DNM3 SMARCA4 RAB37 TAP2 HYDIN | 1.05e-05 | 746 | 152 | 19 | 3.40.50.300 |
| Domain | Small_GTPase | 5.03e-05 | 160 | 152 | 8 | IPR001806 | |
| Domain | VDCCAlpha1 | 6.08e-05 | 10 | 152 | 3 | IPR002077 | |
| Domain | Gln-Leu-Gln_QLQ | 6.58e-05 | 2 | 152 | 2 | IPR014978 | |
| Domain | Phosphofurin_acidic_CS-1 | 6.58e-05 | 2 | 152 | 2 | IPR019381 | |
| Domain | Pacs-1 | 6.58e-05 | 2 | 152 | 2 | PF10254 | |
| Domain | SnAC | 6.58e-05 | 2 | 152 | 2 | PF14619 | |
| Domain | QLQ | 6.58e-05 | 2 | 152 | 2 | SM00951 | |
| Domain | ANKS1 | 6.58e-05 | 2 | 152 | 2 | IPR033635 | |
| Domain | QLQ | 6.58e-05 | 2 | 152 | 2 | PS51666 | |
| Domain | SnAC | 6.58e-05 | 2 | 152 | 2 | SM01314 | |
| Domain | SnAC | 6.58e-05 | 2 | 152 | 2 | IPR029295 | |
| Domain | QLQ | 6.58e-05 | 2 | 152 | 2 | PF08880 | |
| Domain | Small_GTP-bd_dom | 6.80e-05 | 167 | 152 | 8 | IPR005225 | |
| Domain | SNF2_N | 1.27e-04 | 32 | 152 | 4 | IPR000330 | |
| Domain | SNF2_N | 1.27e-04 | 32 | 152 | 4 | PF00176 | |
| Domain | Neurexin-like | 1.80e-04 | 14 | 152 | 3 | IPR003585 | |
| Domain | 4.1m | 1.80e-04 | 14 | 152 | 3 | SM00294 | |
| Domain | VDCC_T_a1 | 1.96e-04 | 3 | 152 | 2 | IPR005445 | |
| Domain | HSA | 3.91e-04 | 4 | 152 | 2 | SM00573 | |
| Domain | HSA | 3.91e-04 | 4 | 152 | 2 | PS51204 | |
| Domain | HSA_dom | 3.91e-04 | 4 | 152 | 2 | IPR014012 | |
| Domain | HSA | 3.91e-04 | 4 | 152 | 2 | PF07529 | |
| Domain | Cyclophilin-type_PPIase | 6.31e-04 | 21 | 152 | 3 | IPR024936 | |
| Domain | MUTSd | 6.47e-04 | 5 | 152 | 2 | SM00533 | |
| Domain | MUTSac | 6.47e-04 | 5 | 152 | 2 | SM00534 | |
| Domain | MutS_V | 6.47e-04 | 5 | 152 | 2 | PF00488 | |
| Domain | Ammonium_transpt | 6.47e-04 | 5 | 152 | 2 | IPR001905 | |
| Domain | DNA_mismatch_repair_MutS_clamp | 6.47e-04 | 5 | 152 | 2 | IPR007861 | |
| Domain | DNA_MISMATCH_REPAIR_2 | 6.47e-04 | 5 | 152 | 2 | PS00486 | |
| Domain | MutS_IV | 6.47e-04 | 5 | 152 | 2 | PF05190 | |
| Domain | MutS_III | 6.47e-04 | 5 | 152 | 2 | PF05192 | |
| Domain | DNA_mismatch_repair_MutS_C | 6.47e-04 | 5 | 152 | 2 | IPR000432 | |
| Domain | DNA_mismatch_repair_MutS_core | 6.47e-04 | 5 | 152 | 2 | IPR007696 | |
| Domain | Ammonium_transp | 6.47e-04 | 5 | 152 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 6.47e-04 | 5 | 152 | 2 | IPR024041 | |
| Domain | RhesusRHD | 6.47e-04 | 5 | 152 | 2 | IPR002229 | |
| Domain | Pro_isomerase | 7.26e-04 | 22 | 152 | 3 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 7.26e-04 | 22 | 152 | 3 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 7.26e-04 | 22 | 152 | 3 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 7.26e-04 | 22 | 152 | 3 | PS50072 | |
| Domain | - | 7.26e-04 | 22 | 152 | 3 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 7.26e-04 | 22 | 152 | 3 | PS00170 | |
| Domain | PRELI/MSF1_dom | 9.66e-04 | 6 | 152 | 2 | IPR006797 | |
| Domain | PRELI_MSF1 | 9.66e-04 | 6 | 152 | 2 | PS50904 | |
| Domain | PRELI | 9.66e-04 | 6 | 152 | 2 | PF04707 | |
| Domain | - | 1.08e-03 | 95 | 152 | 5 | 2.60.120.200 | |
| Domain | Syndecan | 1.35e-03 | 7 | 152 | 2 | PF01034 | |
| Domain | - | 1.35e-03 | 7 | 152 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 1.35e-03 | 7 | 152 | 2 | IPR029020 | |
| Domain | Syndecan/Neurexin_dom | 1.35e-03 | 7 | 152 | 2 | IPR027789 | |
| Domain | PID | 1.49e-03 | 28 | 152 | 3 | PF00640 | |
| Domain | ERAP1-like_C_dom | 1.78e-03 | 8 | 152 | 2 | IPR024571 | |
| Domain | - | 1.78e-03 | 8 | 152 | 2 | 2.60.40.360 | |
| Domain | ERAP1_C | 1.78e-03 | 8 | 152 | 2 | PF11838 | |
| Domain | PID | 2.20e-03 | 32 | 152 | 3 | PS01179 | |
| Domain | PapD-like | 2.28e-03 | 9 | 152 | 2 | IPR008962 | |
| Domain | HlyIII | 3.45e-03 | 11 | 152 | 2 | PF03006 | |
| Domain | AdipoR/HlyIII-related | 3.45e-03 | 11 | 152 | 2 | IPR004254 | |
| Domain | LAM_G_DOMAIN | 3.62e-03 | 38 | 152 | 3 | PS50025 | |
| Domain | Peptidase_M1 | 4.12e-03 | 12 | 152 | 2 | IPR001930 | |
| Domain | PTB | 4.19e-03 | 40 | 152 | 3 | SM00462 | |
| Domain | Laminin_G_2 | 4.19e-03 | 40 | 152 | 3 | PF02210 | |
| Domain | PTB/PI_dom | 4.49e-03 | 41 | 152 | 3 | IPR006020 | |
| Domain | Peptidase_M1_N | 4.84e-03 | 13 | 152 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 4.84e-03 | 13 | 152 | 2 | PF01433 | |
| Domain | LamG | 5.48e-03 | 44 | 152 | 3 | SM00282 | |
| Domain | Myosin_N | 6.44e-03 | 15 | 152 | 2 | PF02736 | |
| Domain | Myosin_N | 6.44e-03 | 15 | 152 | 2 | IPR004009 | |
| Domain | HSP70 | 7.33e-03 | 16 | 152 | 2 | PF00012 | |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 1.89e-09 | 5 | 155 | 4 | 2105501 | |
| Pubmed | 2.62e-08 | 8 | 155 | 4 | 8947846 | ||
| Pubmed | 2.62e-08 | 8 | 155 | 4 | 8195219 | ||
| Pubmed | 7.80e-08 | 10 | 155 | 4 | 10828067 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 1447192 | ||
| Pubmed | ARAP1 regulates the ring size of circular dorsal ruffles through Arf1 and Arf5. | 8.68e-08 | 3 | 155 | 3 | 22573888 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 23783033 | ||
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 8491770 | ||
| Pubmed | 4.99e-07 | 15 | 155 | 4 | 28737171 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 9038142 | ||
| Pubmed | 1.29e-06 | 237 | 155 | 9 | 29564676 | ||
| Pubmed | An Arf/Rab cascade controls the growth and invasiveness of glioblastoma. | 1.72e-06 | 6 | 155 | 3 | 33443570 | |
| Pubmed | WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. | 1.72e-06 | 6 | 155 | 3 | 24768165 | |
| Pubmed | 3.00e-06 | 7 | 155 | 3 | 11950392 | ||
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | SPTLC3 MYH7B OLFML2B QRICH2 LDAH SLC66A1 PACS1 PRELID3A PLA2G4C ARL8B DGAT2 PPIL3 TMEM163 FAM3C LIMCH1 TAP2 | 3.65e-06 | 915 | 155 | 16 | 32393512 |
| Pubmed | 4.78e-06 | 8 | 155 | 3 | 28330839 | ||
| Pubmed | Coated vesicle assembly in the Golgi requires only coatomer and ARF proteins from the cytosol. | 4.78e-06 | 8 | 155 | 3 | 8355790 | |
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 4.78e-06 | 8 | 155 | 3 | 12761855 | |
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 6.36e-06 | 101 | 155 | 6 | 20587610 | |
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 16382099 | ||
| Pubmed | ANXA6 SPAG9 ANKHD1 ARF3 HP1BP3 ANAPC1 SMARCA2 SMARCA4 ANKRD28 HERC2 CNOT1 CPSF3 USP47 | 8.00e-06 | 653 | 155 | 13 | 22586326 | |
| Pubmed | ATP5PB CDK17 MYH7B ANXA6 SPAG9 LDHA LDAH GTF3C5 NDUFA11 ARF4 NAE1 STEAP3 HSPA1A HSPA1B USP47 | 9.83e-06 | 878 | 155 | 15 | 37223481 | |
| Pubmed | ATP5PB CDK17 POLR2B GPAT3 COX7A2 ACOT1 DMXL1 HP1BP3 C5orf34 ERAP2 PPIL3 NAE1 PTRH2 STEAP3 ANKRD28 PPIE HERC2 TIMM44 HSPA1A HSPA1B | 1.10e-05 | 1487 | 155 | 20 | 33957083 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | POLR2B LDHA GTF3C5 ARF1 POLR3A NDUFA11 ARF3 ARF4 ARF5 ANAPC1 AGL NAE1 SMARCA4 TIMM44 HSPA1A HSPA1B CNOT1 CPSF3 | 1.37e-05 | 1257 | 155 | 18 | 37317656 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP5PB COX7A2 LDHA ARF1 ARF3 HP1BP3 ARF4 ARF5 ARL8B PACS2 CACNA1G HSPA1B CNOT1 HYDIN | 1.66e-05 | 807 | 155 | 14 | 30575818 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK17 BUD13 SPAG9 GTF3C5 ARF1 ARF3 ARF4 PACS1 MGST3 ANAPC1 SMARCA2 SMARCA4 PPIE HERC2 CNOT1 USP47 ARAP1 | 1.70e-05 | 1155 | 155 | 17 | 20360068 |
| Pubmed | 1.85e-05 | 12 | 155 | 3 | 30631079 | ||
| Pubmed | Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. | 1.85e-05 | 12 | 155 | 3 | 15749018 | |
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 1.97e-05 | 2 | 155 | 2 | 12411538 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 2868009 | ||
| Pubmed | Adiponectin receptor-1 expression is decreased in the pancreas of obese mice. | 1.97e-05 | 2 | 155 | 2 | 19062045 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 24969908 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 8670841 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 1.97e-05 | 2 | 155 | 2 | 24328534 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 3786141 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 14871887 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22534793 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 23163725 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 2474826 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19909601 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 29237572 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17416799 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 1.97e-05 | 2 | 155 | 2 | 26923070 | |
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.97e-05 | 2 | 155 | 2 | 23076393 | |
| Pubmed | Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma. | 1.97e-05 | 2 | 155 | 2 | 24619866 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 37543682 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 1.97e-05 | 2 | 155 | 2 | 9430716 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 16482515 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15576411 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 1.97e-05 | 2 | 155 | 2 | 11864979 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19549705 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 12846905 | ||
| Pubmed | Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins. | 1.97e-05 | 2 | 155 | 2 | 1899243 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15240517 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15719414 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.97e-05 | 2 | 155 | 2 | 33027072 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26976620 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 23872584 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 18923878 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 1.97e-05 | 2 | 155 | 2 | 21187371 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 1.97e-05 | 2 | 155 | 2 | 20430459 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20235222 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.97e-05 | 2 | 155 | 2 | 23088494 | |
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 1.97e-05 | 2 | 155 | 2 | 20876613 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20223214 | ||
| Pubmed | Dual action of adiponectin on insulin secretion in insulin-resistant mice. | 1.97e-05 | 2 | 155 | 2 | 15358228 | |
| Pubmed | Regulation of adiponectin receptor gene expression in diabetic mice. | 1.97e-05 | 2 | 155 | 2 | 15613685 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20333683 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 34812766 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26627919 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 1.97e-05 | 2 | 155 | 2 | 23704948 | |
| Pubmed | The challenge of understanding ammonium homeostasis and the role of the Rh glycoproteins. | 1.97e-05 | 2 | 155 | 2 | 16564724 | |
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.97e-05 | 2 | 155 | 2 | 30478150 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 30890562 | ||
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 1.97e-05 | 2 | 155 | 2 | 2858050 | |
| Pubmed | The regulation of adiponectin receptors in human prostate cancer cell lines. | 1.97e-05 | 2 | 155 | 2 | 16899222 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 1.97e-05 | 2 | 155 | 2 | 12207910 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28837204 | ||
| Pubmed | MutS homologues hMSH4 and hMSH5: diverse functional implications in humans. | 1.97e-05 | 2 | 155 | 2 | 17127347 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 9787078 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 29572464 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15988927 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19658047 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25892445 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 23255609 | ||
| Pubmed | Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. | 1.97e-05 | 2 | 155 | 2 | 17716299 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 26448330 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20470935 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 12714332 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19299581 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11713291 | ||
| Pubmed | Adipo-R1 and adipo-R2 expression in colorectal adenomas and carcinomas. | 1.97e-05 | 2 | 155 | 2 | 25640382 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 1.97e-05 | 2 | 155 | 2 | 25808524 | |
| Pubmed | Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. | 1.97e-05 | 2 | 155 | 2 | 21108992 | |
| Pubmed | The expression and relationship of AdipoR1/R2 in gastric intestinal metaplasia. | 1.97e-05 | 2 | 155 | 2 | 33851685 | |
| Pubmed | Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70). | 1.97e-05 | 2 | 155 | 2 | 31320473 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 18310295 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 1.69e-04 | 151 | 155 | 5 | chr2q21 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.17e-08 | 31 | 105 | 6 | 357 | |
| GeneFamily | Adiponectin receptors|Progestin and adipoQ receptor family | 3.34e-05 | 2 | 105 | 2 | 293 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.72e-04 | 19 | 105 | 3 | 909 | |
| GeneFamily | MutS homologs|PWWP domain containing | 3.30e-04 | 5 | 105 | 2 | 1026 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.49e-04 | 26 | 105 | 3 | 253 | |
| GeneFamily | Solute carriers | RHCG SLCO1B3 SLC1A1 RHAG SLC7A9 SLC9C1 SLC25A2 SLC6A5 SLC2A13 | 4.91e-04 | 395 | 105 | 9 | 752 |
| GeneFamily | SEC14 family|PRELI domain containing | 4.94e-04 | 6 | 105 | 2 | 1295 | |
| GeneFamily | Progestin and adipoQ receptor family | 1.78e-03 | 11 | 105 | 2 | 930 | |
| GeneFamily | Myosin heavy chains | 3.34e-03 | 15 | 105 | 2 | 1098 | |
| GeneFamily | Heat shock 70kDa proteins | 4.29e-03 | 17 | 105 | 2 | 583 | |
| GeneFamily | Aminopeptidases|CD molecules | 4.29e-03 | 17 | 105 | 2 | 104 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.70e-05 | 156 | 152 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.13e-07 | 179 | 154 | 8 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-07 | 184 | 154 | 8 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 3.10e-07 | 188 | 154 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 3.50e-07 | 191 | 154 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.00e-06 | 168 | 154 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-06 | 173 | 154 | 7 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 176 | 154 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-06 | 180 | 154 | 7 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-06 | 186 | 154 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-06 | 196 | 154 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-06 | 196 | 154 | 7 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | droplet-Bladder-BLADDER-1m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-06 | 197 | 154 | 7 | 1e24150c5146c93914aaaa981bd17589e8ed7cf9 | |
| ToppCell | droplet-Bladder-BLADDER|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-06 | 197 | 154 | 7 | 5ae84f796005fa7b75d10b6464770da6cd5c8f53 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.11e-06 | 199 | 154 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.11e-06 | 199 | 154 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-06 | 199 | 154 | 7 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-05 | 145 | 154 | 6 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 167 | 154 | 6 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 175 | 154 | 6 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 175 | 154 | 6 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-05 | 178 | 154 | 6 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-05 | 179 | 154 | 6 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-05 | 179 | 154 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 179 | 154 | 6 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 3.88e-05 | 180 | 154 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 180 | 154 | 6 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 180 | 154 | 6 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.00e-05 | 181 | 154 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.25e-05 | 183 | 154 | 6 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 183 | 154 | 6 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 4.25e-05 | 183 | 154 | 6 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 183 | 154 | 6 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.39e-05 | 184 | 154 | 6 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 154 | 6 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 154 | 6 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.52e-05 | 185 | 154 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.52e-05 | 185 | 154 | 6 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.66e-05 | 186 | 154 | 6 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 186 | 154 | 6 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 4.80e-05 | 187 | 154 | 6 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-05 | 187 | 154 | 6 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 4.94e-05 | 188 | 154 | 6 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.09e-05 | 189 | 154 | 6 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 5.09e-05 | 189 | 154 | 6 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 5.24e-05 | 190 | 154 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 5.55e-05 | 192 | 154 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.55e-05 | 192 | 154 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 5.72e-05 | 193 | 154 | 6 | f31398dad5321a7bcb27e208bd73630e9756e897 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.72e-05 | 193 | 154 | 6 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.05e-05 | 195 | 154 | 6 | 4759018a7c016cb2e3df5696f1e5f912c7c9ee17 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.05e-05 | 195 | 154 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.05e-05 | 195 | 154 | 6 | def0a3fb36eec6fbb08e1323baf2b22b28bf751a | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-05 | 197 | 154 | 6 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.40e-05 | 197 | 154 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 6.40e-05 | 197 | 154 | 6 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.40e-05 | 197 | 154 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-RBC|COVID-19_Mild / Disease, condition lineage and cell class | 6.40e-05 | 197 | 154 | 6 | 3bae601e5d9689ea57e923814af8cdcae690becc | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.40e-05 | 197 | 154 | 6 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.40e-05 | 197 | 154 | 6 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.59e-05 | 198 | 154 | 6 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.59e-05 | 198 | 154 | 6 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(4)_1wkpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 6.61e-05 | 122 | 154 | 5 | b2a070939c0660c82a1130ef423fd627e9e087ab | |
| ToppCell | 10x5'v1-week_14-16|World / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 199 | 154 | 6 | 9537754bdaeba557bf8b304374082bcfbf28f40f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-05 | 199 | 154 | 6 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.77e-05 | 199 | 154 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.77e-05 | 199 | 154 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-05 | 199 | 154 | 6 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.77e-05 | 199 | 154 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 199 | 154 | 6 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.77e-05 | 199 | 154 | 6 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.96e-05 | 200 | 154 | 6 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | supra_basal_cell|World / shred by cell class for nasal brushing | 6.96e-05 | 200 | 154 | 6 | 542bdcec563644e01887fd85eb158b32db439b03 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.96e-05 | 200 | 154 | 6 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.96e-05 | 200 | 154 | 6 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.96e-05 | 200 | 154 | 6 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.60e-05 | 132 | 154 | 5 | 617644597726e881cd343e57f6edb5a98473b421 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 81 | 154 | 4 | 8cb94dda18010b3b05e5ab72235850483013c03a | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.10e-04 | 156 | 154 | 5 | 8353f98e7d393d4299ed1da8f66cfbc7176df1b5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.43e-04 | 161 | 154 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.50e-04 | 162 | 154 | 5 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-04 | 163 | 154 | 5 | 7864e966c228282b4b63c43164dba3faba21026d | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-04 | 165 | 154 | 5 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 165 | 154 | 5 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 167 | 154 | 5 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 167 | 154 | 5 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 168 | 154 | 5 | 69dd747be46e7fbcec571cddd6dee374b9c2507a | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-04 | 168 | 154 | 5 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 168 | 154 | 5 | ce9fae8b295c668b0959d5007a8bcd401d80e258 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-04 | 168 | 154 | 5 | e40a3f85be7e9bb23bfbc1f9cb5e5fc54bb43863 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-04 | 168 | 154 | 5 | b1d6c35a5ae69c8638afd68c2be5bc9ce6fd2659 | |
| ToppCell | Ionocyte|World / Class top | 3.12e-04 | 170 | 154 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.12e-04 | 170 | 154 | 5 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 94 | 154 | 4 | 00b932421d77f0fd8d6ffe439c992ebc95ad7c94 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 171 | 154 | 5 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 171 | 154 | 5 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 171 | 154 | 5 | 584a095ddcbf78aa29527f84b46b5ad3e2edbaa9 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 171 | 154 | 5 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-04 | 172 | 154 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| Disease | ornithine measurement | 3.14e-06 | 44 | 152 | 5 | EFO_0009776 | |
| Disease | femoral neck bone mineral density | 8.51e-06 | 196 | 152 | 8 | EFO_0007785 | |
| Disease | 2-stearoylglycerophosphocholine measurement | 2.64e-05 | 2 | 152 | 2 | EFO_0021098 | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.85e-05 | 12 | 152 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.83e-05 | 15 | 152 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 2.61e-04 | 5 | 152 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.61e-04 | 5 | 152 | 2 | C3281201 | |
| Disease | complement C4b measurement | 2.84e-04 | 25 | 152 | 3 | EFO_0008092 | |
| Disease | Drug habituation | 3.30e-04 | 115 | 152 | 5 | C0013170 | |
| Disease | Drug abuse | 3.30e-04 | 115 | 152 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.30e-04 | 115 | 152 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 3.30e-04 | 115 | 152 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 3.30e-04 | 115 | 152 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.30e-04 | 115 | 152 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.30e-04 | 115 | 152 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.30e-04 | 115 | 152 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.30e-04 | 115 | 152 | 5 | C0029231 | |
| Disease | Substance abuse problem | 3.44e-04 | 116 | 152 | 5 | C0740858 | |
| Disease | L-arginine measurement | 3.58e-04 | 27 | 152 | 3 | EFO_0006524 | |
| Disease | Barrett's esophagus | 3.99e-04 | 28 | 152 | 3 | EFO_0000280 | |
| Disease | radiation-induced disorder | 4.03e-04 | 67 | 152 | 4 | EFO_0009565 | |
| Disease | neuroimaging measurement | RAD51B NBEAL1 GJC1 ARMC9 MSH5 PPWD1 ARF1 NDUFA11 HP1BP3 ALDH1A2 SMARCA2 FAM3C AGBL1 GABBR1 ANKS1A | 4.33e-04 | 1069 | 152 | 15 | EFO_0004346 |
| Disease | lactadherin measurement | 5.44e-04 | 7 | 152 | 2 | EFO_0008203 | |
| Disease | 1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement | 5.44e-04 | 7 | 152 | 2 | EFO_0800470 | |
| Disease | electrodermal activity measurement, skin conductance response amplitude | 5.44e-04 | 7 | 152 | 2 | EFO_0006866, EFO_0006868 | |
| Disease | 1-oleoyl-2-linoleoyl-GPE (18:1/18:2) measurement | 5.44e-04 | 7 | 152 | 2 | EFO_0800443 | |
| Disease | nucleotide measurement | 5.59e-04 | 73 | 152 | 4 | EFO_0010513 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 7.23e-04 | 8 | 152 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | creatine measurement | 8.45e-04 | 36 | 152 | 3 | EFO_0010472 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 9.27e-04 | 9 | 152 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement | 9.27e-04 | 9 | 152 | 2 | EFO_0800409 | |
| Disease | Major depression, single episode | 9.27e-04 | 9 | 152 | 2 | C0024517 | |
| Disease | psoriatic arthritis | 1.08e-03 | 87 | 152 | 4 | EFO_0003778 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement | 1.15e-03 | 10 | 152 | 2 | EFO_0800402 | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.41e-03 | 11 | 152 | 2 | EFO_0800269 | |
| Disease | maleate measurement | 1.41e-03 | 11 | 152 | 2 | EFO_0010509 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | 1.41e-03 | 11 | 152 | 2 | EFO_0004276, EFO_0004775, EFO_0020996 | |
| Disease | triacylglycerol 53:2 measurement | 1.68e-03 | 12 | 152 | 2 | EFO_0021484 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.68e-03 | 12 | 152 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.96e-03 | 48 | 152 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.98e-03 | 13 | 152 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 1.98e-03 | 13 | 152 | 2 | C0265338 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 1.98e-03 | 13 | 152 | 2 | C0238288 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.98e-03 | 13 | 152 | 2 | EFO_0800474 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 1.98e-03 | 13 | 152 | 2 | OBA_2045174 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 2.09e-03 | 104 | 152 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | coronary artery disease, factor VII measurement | 2.64e-03 | 111 | 152 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 2.65e-03 | 15 | 152 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | response to olanzapine | 2.65e-03 | 15 | 152 | 2 | GO_0097333 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 2.65e-03 | 15 | 152 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 2.65e-03 | 15 | 152 | 2 | OBA_2045067 | |
| Disease | factor VIII measurement, coronary artery disease | 2.82e-03 | 113 | 152 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 3.01e-03 | 115 | 152 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | 4-acetamidobutanoate measurement | 3.02e-03 | 16 | 152 | 2 | EFO_0021003 | |
| Disease | triiodothyronine measurement | 3.02e-03 | 16 | 152 | 2 | EFO_0008392 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 3.30e-03 | 118 | 152 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | Glycogen storage disease | 3.41e-03 | 17 | 152 | 2 | cv:C0017919 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.41e-03 | 17 | 152 | 2 | OBA_2045173 | |
| Disease | phosphatidylcholine measurement | 3.63e-03 | 284 | 152 | 6 | EFO_0010226 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 3.82e-03 | 18 | 152 | 2 | OBA_2045175 | |
| Disease | Schizophrenia | 3.82e-03 | 18 | 152 | 2 | cv:C0036341 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.82e-03 | 18 | 152 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 3.82e-03 | 18 | 152 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 3.82e-03 | 18 | 152 | 2 | OBA_2045065 | |
| Disease | free cholesterol in IDL measurement | 3.88e-03 | 61 | 152 | 3 | EFO_0022181 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.88e-03 | 61 | 152 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | cutaneous melanoma, hair color | 4.06e-03 | 62 | 152 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 4.26e-03 | 19 | 152 | 2 | EFO_0802076 | |
| Disease | primary biliary cirrhosis | 5.04e-03 | 133 | 152 | 4 | EFO_1001486 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLLAGKGFAVMALAY | 176 | Q86TX2 | |
| HMYSGAKTGLVLTDI | 421 | Q9BRD0 | |
| TKISYEIGLMNFVLG | 151 | Q9H305 | |
| KALYLGRVMETGVID | 1181 | P78357 | |
| MIEIAGVKLLYTGDF | 166 | Q9UKF6 | |
| PLSALYMGALIKEAG | 216 | O94788 | |
| LMVGLDAAGKTTILY | 21 | P84085 | |
| GGMTIVYKNSIDLFL | 96 | Q9P299 | |
| TYDMIGGLSSQLKAI | 351 | Q8NB90 | |
| GLIVMINESKGDAIY | 896 | Q8WXG9 | |
| GLMGKVLVSYATLDD | 2006 | Q8WXG9 | |
| SGMISVVKYLLDLGV | 216 | O15084 | |
| LMVGLDAAGKTTILY | 21 | P61204 | |
| YLGSMLIKDLRGTES | 946 | Q92625 | |
| KGGVADALLYRATMI | 46 | P14406 | |
| YAEVKRVGDTLLGMA | 521 | Q9HCK5 | |
| LKMSAYSGITDVIIG | 206 | Q96HY7 | |
| GVQSLLMYKDGDSVL | 461 | Q8IV53 | |
| SHILTVGIGSKLFMY | 1151 | Q9Y485 | |
| TALSVLGVMVYGIKK | 101 | P24539 | |
| YMISKGGSEALLQTL | 46 | Q96MI9 | |
| LGIGKVMEETLSYLL | 206 | P05089 | |
| YELTGKFERLIVGLM | 76 | P08133 | |
| LLGGSLMEYAILSAI | 336 | Q5SSJ5 | |
| VYFGIAASLVKMGRL | 116 | Q86Y39 | |
| IGYTHMLEVLKSLGQ | 401 | Q6ZS30 | |
| LELMKVTGLSYRGVH | 36 | O15315 | |
| SKLDYSGIALLIMGS | 216 | Q86V24 | |
| YDLTGKVMLLGDTGV | 26 | Q96AX2 | |
| LSKTMYLEDGTIGLR | 51 | Q9H0N0 | |
| LSKTMYLEDGTIGLR | 51 | Q53S08 | |
| FHLMGELSSLYVGLK | 1031 | Q9H0J4 | |
| SDMYKALLAEAGIPL | 411 | O94810 | |
| GNGLMIVSYKSLTFV | 241 | Q96RS6 | |
| LKSMLVISGGEGYID | 1266 | O60271 | |
| MIKGLYGIKDDVFLS | 276 | P00338 | |
| LTYATTLLEAMKGGE | 271 | Q15124 | |
| TLLEGMLFSLKYLGM | 41 | Q5SW96 | |
| YLTKGHEMTSIGLLL | 1196 | Q9H1A4 | |
| MELTLVGLQYSGKTT | 21 | Q9NVJ2 | |
| MELTLVGLQYSGKTT | 21 | Q96BM9 | |
| YLGSMLIKELRGTES | 1066 | Q7Z6G8 | |
| LKAIQDGTIVLMGTY | 136 | Q92520 | |
| YGLTVALLAMGLDSI | 201 | Q9H346 | |
| KLDYSGIALLIMGSF | 206 | Q96A54 | |
| MGIKTALPAAELGLY | 1 | Q9HCP6 | |
| MKEAALIYLDRSGGL | 6 | Q4G0Z9 | |
| LAGGVIIYIMKHSLS | 146 | Q9UPQ8 | |
| ELMGVGSLLKKYTAL | 1081 | O95714 | |
| ALVMLGNTLYGLSVL | 221 | Q6ZP29 | |
| YATVGLLVGMDVLTL | 711 | Q9UBS5 | |
| GEKLLTTEYLGIMTN | 616 | Q7Z3E5 | |
| GILMGLAVYNSITLD | 506 | Q5U5R9 | |
| MYQALKEALGIIGDI | 731 | Q9UQ16 | |
| MAKAAAIGIDLGTTY | 1 | P0DMV9 | |
| YLMGVSSGDLLKGLL | 431 | A7E2Y1 | |
| LGMILGTETSNKYEI | 76 | A0PG75 | |
| MYGKIIFVLLLSGIV | 1 | P15421 | |
| LVYMEIESLGIKGFI | 571 | Q9ULK4 | |
| NLYLLLDMGSGTIKV | 516 | Q9Y4C0 | |
| ELMFLLTGGVSLKSA | 2366 | Q6ZR08 | |
| LGLMLGTTEAQTALY | 1871 | P09848 | |
| MYGKSSTRAVLLLLG | 1 | O60487 | |
| TLVKNMISGLSYGAL | 556 | Q8IVH2 | |
| GISYSKGSSILRMLE | 476 | Q07075 | |
| LSEIGFGKMETYIKL | 181 | Q00537 | |
| MAVLSKEYGFVLLTG | 1 | O14880 | |
| YLLLDMGSGTIKIKA | 551 | Q9ULB1 | |
| ILGYKTLAAGSISMA | 126 | Q86VP3 | |
| LAAMLALKYLGPVAA | 76 | O95672 | |
| SDYLMGFINSGILKV | 86 | O94772 | |
| LGYKTLAVGLINMAE | 206 | Q6VY07 | |
| MGSDLGLIILSYALI | 216 | Q8NGI1 | |
| SMGILKVYTIEESGL | 1821 | Q5VYJ5 | |
| MKEQGLLDAVTYLAG | 66 | Q9UP65 | |
| ISGTIAIEMDKGTYI | 56 | Q14331 | |
| GKMVKLYVLGSVLAL | 21 | P27469 | |
| EMGLGKTIQSITFLY | 886 | Q3L8U1 | |
| ALTALGKLLYLLDGM | 456 | Q969S8 | |
| ITMKGLDYIDVLSGS | 4776 | Q4G0P3 | |
| DSKYFGRGIMIAILV | 741 | O43497 | |
| SVFGVSLGISEIYMK | 26 | Q53EU6 | |
| MVIIYAIIGLELFKG | 206 | Q13698 | |
| TEKTIFLLIMYGVTG | 226 | P36383 | |
| AGREGHMLKVLSYIS | 331 | P82251 | |
| VGEMTLKVVSLGLYF | 1216 | Q9P0X4 | |
| QKGLRYGMILFITSE | 76 | P00414 | |
| LMVGLDAAGKTTILY | 21 | P84077 | |
| MKFEIGEALYLGIIS | 156 | P57739 | |
| GAGRLTLDKALDMTY | 671 | Q6P179 | |
| MYTTLRDGLIVTGGK | 1601 | Q6ZMW3 | |
| MAKAAAIGIDLGTTY | 1 | P0DMV8 | |
| GMVKSLLYQILDGIH | 126 | P49336 | |
| IYMESGIVKITSLDG | 116 | Q96MH7 | |
| MATTKRVLYVGGLAE | 1 | Q9UNP9 | |
| LLAGIAYKVNILMSG | 86 | Q99500 | |
| KLGLYMATVLTGLAI | 281 | P43005 | |
| MKTLIAAYSGVLRGE | 1 | Q96PD7 | |
| GKGAAMIIETLNLYF | 1021 | Q9UPQ0 | |
| YLGSMAVSDLLILLG | 76 | O43193 | |
| YGLTMALLVIGLDVL | 216 | Q8NGH7 | |
| ILSVLAGLAAMVGYA | 421 | Q13505 | |
| YLKQVGLITFMALVG | 601 | O43196 | |
| GYDTGVVSGAMLLLK | 96 | Q96QE2 | |
| TVKGVSLSSYLEGLM | 131 | Q9Y3B1 | |
| MGLGKTIQTIALITY | 751 | P51531 | |
| GIYIIISGMVKLEKS | 906 | Q4G0N8 | |
| VTGFLVLMSEGLYKA | 281 | Q15750 | |
| SKLDFILSMVGYAVG | 196 | Q9Y345 | |
| QLFEKMISGLYLGEL | 291 | Q2TB90 | |
| LRTTVGMDGTLYKIH | 406 | Q2TB90 | |
| LYGTMLGIKVINVET | 371 | Q96BP3 | |
| TVKGISLGSYLESLM | 131 | Q96N28 | |
| LLYGVLDHRMGTSEK | 51 | O14802 | |
| MGLGKTIQTIALITY | 781 | P51532 | |
| GLVKNLALMAYISVG | 521 | P30876 | |
| LLRSLVKVVGLYGFM | 271 | Q03519 | |
| DIAGMISQLGEKYSL | 511 | O15457 | |
| IGNLGMVILTYLDSK | 46 | Q8NGG5 | |
| KLGASVIEILGIEYM | 261 | Q9Y253 | |
| KILILVEGVYSMEGS | 301 | Q9NUV7 | |
| AYLMGLNSADLLKGL | 386 | P13533 | |
| KLSTIIDMLEGAFYG | 146 | Q68BL8 | |
| GIVALYSGLKATMIR | 261 | Q9BXI2 | |
| LMVGLDAAGKTTILY | 21 | P18085 | |
| DLFMLYVLVTEKGGL | 271 | Q99856 | |
| LLYLASRVGDTKHGM | 1266 | Q96P48 | |
| LMAASSGGYLDIVKL | 276 | Q8IWZ3 | |
| LNGKAYGSVMILVTS | 406 | Q9UQC9 | |
| YGSVMILVTSGDDKL | 411 | Q9UQC9 | |
| LHLAYVTSMGKLRGV | 846 | P35523 | |
| EITSKGASLYDLLGM | 146 | Q96AJ1 | |
| LFGGIIEKGLVTYMA | 916 | A5YKK6 | |
| IEKGLVTYMALGLAL | 921 | A5YKK6 | |
| YGLIIDGAALSLIMK | 756 | P98196 | |
| ASILGDSGEYKMILV | 56 | Q9Y3E5 | |
| GIGLLTTFMYANKSI | 176 | Q5M7Z0 | |
| LKNVLAASAGGMLTY | 61 | Q9H1C4 | |
| KYVGMILSVLTGLLF | 211 | O95070 | |
| RMEIYLSLGVLALGT | 356 | Q658P3 | |
| MMGSLVYLRLGLEKS | 236 | Q96G75 | |
| LDMKYTVFGKVIDGL | 111 | Q9H2H8 | |
| FSYIAKALGGIIMKI | 36 | Q9NPD5 | |
| SATYDLGATLLKMGI | 311 | P05543 | |
| GQKLVAAYVLGLLTM | 216 | O75425 | |
| AYVLVGAGVMLLLLS | 66 | Q9NW97 | |
| GLLLGGVKSTYMFDL | 681 | Q96K76 | |
| SIAGMVSVLGYKFLT | 301 | Q02094 | |
| YKRFLDEGGMVLTTL | 176 | O95473 | |
| GKFQIYGLLVTLAMA | 391 | Q9UBD6 | |
| LLGGLFSKTEMSEVL | 286 | O43615 | |
| MEILGIISTIYKFQG | 111 | Q9Y5Q8 | |
| LSGGSMLDIIKYIVN | 141 | Q9UEW8 | |
| LTGFLQEYGLSVMVK | 461 | Q13564 | |
| GLTIFAYGVKLLIDM | 261 | Q8TC26 | |
| SKLGSMYGEQILSVV | 101 | Q6UXP3 | |
| LKIFLYHDGLVRMGT | 216 | Q6ZT98 | |
| RMSTSKVTVLGYGLL | 121 | Q5FWF4 | |
| LKYAGLQGLMSVLAE | 931 | P35573 | |
| MKLVLIGHSIGSYFT | 131 | Q9H6V9 | |
| KSLVYGIVGAVMAVL | 5376 | Q9UKN1 | |
| LAMLSYGVTTLGLTK | 126 | Q9BTE0 |